Skip to contentZ
Zivo Bioscience, Inc.
Z
ZIVOZivo Bioscience, Inc. Q4 2014 · 10-K
derived · Computed from the longer spans the company filed.
Revenue$0.00$0.00derived— vs Q4 2013 Net Income$726.26K$726.26Kderived+178.0% vs Q4 2013 EPS, diluted—
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Zivo Bioscience, Inc. · CIK 1101026 · Engraved from SEC EDGAR
Not derived. Share counts vary by quarter.
Operating Cash Flowderived-$297,886— ended Dec 31, 2014 · filed Apr 6, 2015 · 96 d after period end